Main Article Content

Abstract

Psychiatric manifestations associated with HIV infection are varied and can present a diagnostic challenge, particularly in immunocompromised patients. We report a case of an acute psychotic episode associated with HIV infection in a patient who was not receiving regular care. The patient was a 43-year-old woman who had been living with HIV for 11 years and had been adhering to her antiretroviral treatment irregularly; she was admitted for progressive psychomotor agitation that had been developing over the previous two weeks. The psychiatric assessment revealed persecutory delusions, logorrhoea and hetero-aggression. A brain CT scan and cerebrospinal fluid analysis were normal. Immunovirological testing showed a CD4 lymphopenia of 186 cells/mm³ and a viral load of 58 copies/mL. Given the severe agitation, sedation with intramuscular ketamine was required. The patient’s condition stabilised psychiatrically on haloperidol, with a resumption of antiretroviral therapy and a reduction in delusions. Acute psychotic episodes associated with HIV can occur at an advanced stage of immunosuppression and require urgent multidisciplinary management involving psychiatrists, infectious disease specialists and emergency physicians.

Keywords

HIV acute psychosis neurpsychiatric symptoms immunosuppression VIH Psychose aigue manifestations neuropsychiatriques immunodépression

Article Details

How to Cite
Hilda Birinda, Davy Nzamba, Stéphane Oliveira, Raphael Okoue Ondo, Yannick Armand Ivala Mendome, Fanie Nelie Chela Tchibinda Ali, … Romain Tchoua. (2026). An Acute Psychotic Episode Indicating an HIV-Associated Neuropsychiatric Disorder at the Akanda Military Teaching Hospital (Gabon): Épisode Psychotique Aigu Révélateur d’une Atteinte Neuropsychiatrique Associée au VIH à l’Hôpital d’Instruction des Armées d’Akanda (Gabon). HEALTH SCIENCES AND DISEASE, 27(8), 94–97. https://doi.org/10.67260/hsd.v27i8.7842

References

  1. 1. World Health Organization. Guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: WHO; 2021.
  2. 2. Wang T, Fu H, Kaminga AC, et al. Prevalence of depression or depressive symptoms among people living with HIV/AIDS in China: a systematic review and meta-analysis. BMC Psychiatry. 2018;18:160.
  3. 3. Antelman G, Kaaya S, Wei R, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44(4):470-7.
  4. 4. Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2021;97(5):e489-e499.
  5. 5. Sewell DD. Schizophrenia and HIV. Schizophr Bull. 1996;22(3):465-73.
  6. 6. Capriotti Z, Klase Z. Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications. J Neurovirol. 2024;30(5-6):451-476.
  7. 7. Arizono K, Sedohara A, Tuvshinjargal K, et al. MicroRNA in neuroexosome as a potential biomarker for HIV-associated neurocognitive disorders. J Neurovirol. 2025;31:56-74.
  8. 8. Luo H, Chen J, Liu J, et al. Bridging brain and blood: a prospective view on neuroimaging-exosome correlations in HIV-associated neurocognitive disorders. Front Neurol. 2025;15:1479272.
  9. 9. Satriano J, Claassen J. Behavioral emergencies in the acute care setting. Emerg Med Clin North Am. 2015;33(4):749-68.
  10. 10. Lin Y, Vu D, Salottolo K, et al. Efficacy and safety of ketamine for acute agitation in the emergency department: a systematic review. Am J Emerg Med. 2023;67:34-41.
  11. 11. Millogo A, Ki-Zerbo GA, Andonaba JB, et al. Manifestations neurologiques et psychiatriques de l’infection à VIH en Afrique subsaharienne. Med Afr Noire. 2012;59(4):215-22.